| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | Canada | 3 | |
| #3 | China | 3 | |
| #4 | United States | 3 | |
| #5 | Brazil | 2 | |
| #6 | EPO (European Patent Office) | 2 | |
| #7 | Luxembourg | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Machines | |
| #4 | Measurement | |
| #5 | Computer technology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wagner Daniel R | 15 |
| #2 | Devaux Yvan | 10 |
| #3 | Rouy Didier | 4 |
| #4 | Yvan Devaux | 3 |
| #5 | Vausort Melanie | 2 |
| #6 | Muller Claude | 2 |
| #7 | Wagner Daniel | 2 |
| #8 | Mueller Konstantin | 2 |
| #9 | Azuaje Francisco | 2 |
| #10 | Francisco Azuaje | 1 |
| Publication | Filing date | Title |
|---|---|---|
| LU91725A1 | Novel uses of V-ATPASE inhibitors | |
| WO2010070136A2 | Novel caviidae allergens and uses thereof | |
| CA2741117A1 | Biomarkers for heart failure | |
| US2011035818A1 | Diagnostic marker and platform for drug design in myocardial infarction and heart failure | |
| CN101646434A | The purposes of adenosine antagonist | |
| EP1782068A1 | Monitoring heart failure |